| 7993830 |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Gang An |
2011-08-09 |
| 7332270 |
Diagnosis of disease state using mRNA profiles in peripheral leukocytes |
David A. Ralph, Gang An, S. Mark O'Hara |
2008-02-19 |
| 6463438 |
Neural network for cell image analysis for identification of abnormal cells |
Kaveh Ashenayi, Ying Hu, Gerard J. O'Dowd |
2002-10-08 |
| 6369195 |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Gang An |
2002-04-09 |
| 6218529 |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
Gang An, S. Mark O'Hara, David A. Ralph |
2001-04-17 |
| 6190857 |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
David A. Ralph, Gang An, S. Mark O'Hara |
2001-02-20 |
| 6156515 |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Gang An |
2000-12-05 |
| 6025128 |
Prediction of prostate cancer progression by analysis of selected predictive parameters |
Michael Patrick Bacus, M. Craig Miller, Kaveh Ashenayi, Donald P. Coffey, Alan W. Partin +1 more |
2000-02-15 |
| 5989811 |
Sextant core biopsy predictive mechanism for non-organ confined disease status |
M. Craig Miller, Michael Patrick Bacus, Kaveh Ashenayi |
1999-11-23 |
| 5882864 |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
Gang An, S. Mark O'Hara, David A. Ralph |
1999-03-16 |
| 5856112 |
Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof |
Garry M. Marley |
1999-01-05 |
| 5102909 |
Pharmaceutically useful furyl substituted dihydroxyethylbutyrolactones |
Gabor Fodor, Kawporn Sussangkarn |
1992-04-07 |
| 5098933 |
Pharmaceutically useful Michael addition products of unsaturated aldehydes and ketones and ascorbic acid |
Gabor Fodor |
1992-03-24 |
| 4963364 |
Microencapsulated antitumor agent |
Sidney W. Fox |
1990-10-16 |
| 4883808 |
Condensation products of cyclic diketones and ascorbic acid as immunomodulatory agents |
Gabor Fodor, Kawporn Sussangkarn |
1989-11-28 |
| 4883813 |
Method of treating inflammation in mammals utilizing ketobutyrolactones and furylbutyrolactones |
Peter E. Maxim |
1989-11-28 |
| 4617262 |
Assaying for circulating immune complexes with labeled protein A |
Peter E. Maxim |
1986-10-14 |
| 4518611 |
2-Furylbutyrolactone modulation of the immune system in mammals |
— |
1985-05-21 |
